Rundu shares: passed the GMP certification of the Brazilian National Health Surveillance Agency

2025-06-27 18:51:53

Rundu shares announced that the company accepted the on-site GMP certification of the Brazilian National Health Surveillance Agency from March 17, 2025 to March 21, 2025, and the certification scope was chemical raw materials: candesartan cilexetil, sacubitril valsartan sodium, telmisartan, and valsartan. Recently, the company received two GMP certification certificates issued by Brazil's ANVISA, which are valid until May 26, 2027 and June 9, 2027. The conclusion of the on-site inspection by Brazil's ANVISA is qualified, that is, the company's four raw material products have passed the Brazilian ANVISA on-site GMP certification.

VIS Visa

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    South Korean Ministry of Foreign Affairs: U.S. Secretary of State Rubio and South Korean and Japanese diplomats agreed to strengthen cooperation in areas such as energy, shipbuilding, and supply chain security (including critical minerals and artificial intelligence).
                            2025-07-11

                                    CoreWeave becomes the first hyperscale cloud service provider to deploy NVIDIA's GB300 NVL72 platform.
                            2025-07-04

                                    TSMC (TSM.N) responded to the Wall Street Journal report by saying its investment in the United States will not affect its existing investment plans in other regions.
                            2025-07-04

                                    Market news: Apple (AAPL.O) plans to launch new MacBook Pro, iPhone 17E and iPad in early 2026.
                            2025-07-11

                                    Shanghai: The scale of the city's artificial intelligence industry exceeded 118 billion yuan in the first quarter of this year
                            2025-07-10